




Instance: composition-en-0d9fdb5a39ccb7b71c8ef7225226fb5e
InstanceOf: CompositionUvEpi
Title: "Composition for emselex Package Leaflet"
Description:  "Composition for emselex Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mp0d9fdb5a39ccb7b71c8ef7225226fb5e)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - emselex"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What is in this leaflet</p>
<ol>
<li>What Emselex is and what it is used for </li>
<li>What you need to know before you take Emselex </li>
<li>How to take Emselex </li>
<li>Possible side effects </li>
<li>How to store Emselex </li>
<li>Contents of the pack and other information  </li>
</ol>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What emselex is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What emselex is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>How Emselex works 
Emselex reduces the activity of an overactive bladder. This enables you to wait longer before you go 
to the toilet and it increases the amount of urine that your bladder can hold. </p>
<p>What Emselex can be used for 
Emselex belongs to a class of medicines which relax the muscles of the bladder. It is used in adults for 
the treatment of the symptoms of overactive bladder conditions - such as a sudden urge to rush to the 
toilet, needing to go to the toilet frequently and/or not getting to the toilet in time and wetting yourself 
(urge incontinence). </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take emselex"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take emselex"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Do not take Emselex: 
* if you are allergic to darifenacin or any of the other ingredients of this medicine (listed in 
section 6). 
* if you suffer from urinary retention (inability to empty your bladder). 
* if you have gastric retention (problems emptying the contents of the stomach). 
* if you suffer from uncontrolled narrow-angle glaucoma (high pressure in the eyes that is not 
being adequately treated). 
* if you have myasthenia gravis (a disease marked by unusual tiredness and weakness of selected 
muscles). 
* if you have severe ulcerative colitis or toxic megacolon (acute dilation of the colon due to 
complication of infection or inflammation). 
* if you have severe liver problems. 
* if you are taking medicines that strongly decrease the activity of some liver enzymes such as 
ciclosporin (a medicine used in transplantation to prevent organ rejection or for other 
conditions, e.g. rheumatoid arthritis or atopic dermatitis), verapamil (a medicine used to lower 
blood pressure, to correct heart rhythm or to treat angina pectoris), antifungal medicines (e.g. 
ketoconazole and itraconazole) and some antiviral medicines (e.g. ritonavir)  see paragraph 
 Other medicines and Emselex ). </p>
<p>Warnings and precautions 
Talk to your doctor  before taking Emselex 
* if you have autonomic neuropathy (damage to the nerves that communicate between the brain 
and internal organs, muscles, skin, and blood vessels to regulate vital functions, including the 
heart rate, blood pressure and bowel function)   your doctor will have told you if you have this. 
* if you have a condition where one or more organs in your abdomen has moved up into your 
chest through a hole in your diaphragm, causing you to get heartburn and belch a lot. 
* if you have difficulties in passing urine and a weak stream of urine. 
* if you have severe constipation (less than or equal to 2 bowel movements per week). 
* if you have a digestive motility disorder. 
* if you have an obstructive gastrointestinal disorder (any obstruction of the passage of intestinal 
or gastric contents, such as narrowing of the pylorus, the lower part of the stomach)   your 
doctor will have told you if you have this. 
* if you are taking medicinal products that can cause or worsen inflammation of the oesophagus 
such as oral bisphosphonates (a class of medicinal products that prevent the loss of bone mass 
and are used to treat osteoporosis). 
* if you are receiving treatment for narrow-angle glaucoma. 
* if you have liver problems. 
* if you have urinary tract infection or other kidney problems.<br />
* if you have an overactive muscle that controls the emptying of the bladder which may cause 
accidental passing of urine (a condition called detrusor hyperreflexia)   your doctor will tell you 
if you are suffering from this condition. 
* if you have heart diseases. 
If any of these apply to you, tell your doctor before you take Emselex. </p>
<p>During treatment with Emselex, tell your doctor straight away and stop taking Emselex if you 
experience swelling of the face, lips, tongue and/or throat (signs of angioedema). </p>
<p>Children and adolescents<br />
Emselex is not recommended for use in children and adolescents (&lt;18 years). </p>
<p>Other medicines and Emselex 
Tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including 
medicines obtained without a prescription. This is particularly important if you are taking any of the 
following as your doctor may need to adjust your dose of Emselex and/or the other medicine: 
* certain antibiotics (e.g. erythromycin, clarithromycin, telithromycin and rifampicin), 
* antifungal medicines (e.g. ketoconazole and itraconazole - see paragraph  Do not take 
Emselex , fluconazole, terbinafine), 
* medicines used to reduce the activity of the immune system, for example, after organ 
transplantation (e.g. ciclosporin - see paragraph  Do not take Emselex ), 
* antiviral medicines (e.g. ritonavir - see paragraph  Do not take Emselex ), 
* antipsychotic medicines (e.g. thioridazine), 
* certain antidepressants (e.g. imipramine and paroxetine), 
* certain anticonvulsants (carbamazepine, barbiturates), 
* certain medicines used to treat heart problems (e.g. verapamil - see paragraph  Do not take 
Emselex , flecainide, digoxin and quinidine), 
* certain medicines used for the treatment of stomach problems (e.g. cimetidine), 
* other antimuscarinic medicines (e.g. tolterodine, oxybutynin and flavoxate). 
Please also inform your doctor if you are taking products containing St John s wort. </p>
<p>Emselex with food and drink 
Eating food has no effect on Emselex. Grapefruit juice may interact with Emselex. Tell your doctor if 
you are taking grapefruit juice regularly. </p>
<p>Pregnancy and breast-feeding 
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask 
your doctor for advice before taking this medicine. 
Emselex is not recommended during pregnancy. 
Emselex should be taken with caution while breast-feeding. </p>
<p>Driving and using machines 
Emselex may cause effects such as dizziness, blurred vision, trouble sleeping or drowsiness. If you 
have any of these symptoms whilst taking Emselex, consult your doctor for advice on changing the 
dose or considering an alternative treatment. You should not drive or use machines if you are affected 
by these symptoms. For Emselex, these side effects have been reported to be uncommon (see 
section 4). </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take emselex"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take emselex"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Always take Emselex exactly as your doctor has told you. You should check with your doctor or 
pharmacist if you are not sure. If you have the impression that the effect of Emselex is too strong or 
too weak, talk to your doctor or pharmacist. </p>
<p>How much Emselex to take 
The recommended starting dose, including for patients aged over 65 years, is 7.5 mg daily. Depending 
on your response to Emselex, your doctor may increase your dose to 15 mg daily, two weeks after 
starting therapy. </p>
<p>These doses are suitable for people with mild liver problems or people with kidney problems. </p>
<p>Take Emselex tablets once a day with liquid, at about the same time each day. </p>
<p>The tablet may be taken with or without food. Swallow the tablet whole. Do not chew, split or crush it. </p>
<p>If you take more Emselex than you should 
If you have taken more tablets than you have been told to take, or if someone else accidentally takes 
your tablets, go to your doctor or hospital for advice immediately. When seeking medical advice, 
make sure that you take this leaflet and your remaining tablets with you to show them to the doctor. 
People who have taken an overdose may have dry mouth, constipation, headache, indigestion and 
nasal dryness. Overdose with Emselex may lead to severe symptoms requiring emergency treatment in 
hospital. </p>
<p>If you forget to take Emselex 
If you forget to take Emselex at the usual time, take it as soon as you remember, unless it is the time 
for your next dose. Do not take a double dose to make up for a forgotten dose. </p>
<p>If you stop taking Emselex 
Your doctor will tell you how long your treatment with Emselex will last. Do not stop treatment early 
because you do not see an immediate effect. Your bladder will need some time to adapt. Finish the 
course of treatment prescribed by your doctor. If you have not noticed any effect by then, discuss it 
with your doctor. </p>
<p>If you have any further questions on the use of this product, ask your doctor or pharmacist. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. The side 
effects caused by Emselex are usually mild and temporary. </p>
<p>Some side effects could be serious 
Not known (frequency cannot be estimated from the available data) 
Serious allergic reactions including swelling, mainly of the face and neck (angioedema). </p>
<p>Other side effects 
Very common (may affect more than 1 in 10 people) 
Dry mouth, constipation. </p>
<p>Common (may affect up to 1 in 10 people) 
Headache, abdominal pain, indigestion, feeling sick, dry eyes, nasal dryness. </p>
<p>Uncommon (may affect up to 1 in 100 people) 
Fatigue, accidental injury, facial swelling, high blood pressure, diarrhoea, flatulence, ulceration of the 
mucous membrane of the mouth, increased liver enzymes (this shows abnormal functioning of the 
liver), swelling including swelling of the hands, ankles or feet, dizziness, sleeplessness, drowsiness, 
abnormal thinking, runny nose (rhinitis), cough, shortness of breath, dry skin, itching, rash, sweating, 
visual disturbance including blurred vision, taste disturbance, urinary tract disorder or infection, 
impotence, discharge and itching in the vagina, bladder pain, inability to empty your bladder. </p>
<p>Not known (frequency cannot be estimated from the available data) 
Depressed mood/mood alterations, hallucination. </p>
<p>Reporting of side effects 
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects 
not listed in this leaflet. You can also report side effects directly via the national reporting system 
listed in Appendix V. By reporting side effects you can help provide more information on the safety of 
this medicine. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store emselex"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store emselex"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <ul>
<li>Keep this medicine out of the sight and reach of children. </li>
<li>Do not use this medicine after the expiry date which is stated on the carton and blister. The 
expiry date refers to the last day of that month. </li>
<li>Keep the blister packs in the outer carton in order to protect from light. </li>
<li>Do not use if the pack is damaged or shows signs of tampering. </li>
<li>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist 
how to throw away medicines you no longer use. These measures will help protect the 
environment. </li>
</ul>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What Emselex contains 
- The active substance is darifenacin. Each tablet contains 7.5 mg darifenacin (as hydrobromide). 
- The other ingredients are calcium hydrogen phosphate (anhydrous), hypromellose, magnesium 
stearate, polyethylene glycol, titanium dioxide (E171) and talc. </p>
<p>What Emselex looks like and contents of the pack 
Emselex 7.5 mg prolonged-release tablets are round, convex white tablets and are debossed with  DF<br />
on one side and  7.5  on the other. </p>
<p>The tablets are available in blister packs containing 7, 14, 28, 49, 56 or 98 tablets or in multipacks 
containing 140 (10x14) tablets. Not all pack sizes may be available in your country. </p>
<p>Marketing Authorisation Holder 
pharmaand GmbH 
Taborstrasse 1 
1020 Vienna 
Austria </p>
<p>Manufacturer 
DREHM Pharma GmbH 
Gr nbergstrasse 15/3/3 
1120 Vienna 
Austria </p>
<p>This leaflet was last revised in </p>
<p>Other sources of information 
Detailed information on this medicine is available on the European Medicines Agency website: 
http://www.ema.europa.eu </p>
<p>Package leaflet: information for the user </p>
<p>Emselex 15 mg prolonged-release tablets 
Darifenacin </p>
<p>Read all of this leaflet carefully before you start taking this medicine because it contains 
important information for you. 
- Keep this leaflet. You may need to read it again. 
- If you have any further questions, ask your doctor or pharmacist. 
- This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even 
if their symptoms are the same as yours. 
If you get any side effects, talk your doctor or pharmacist. This includes any possible side effects not 
listed in this leaflet. See section 4.</p>         </div>"""      



Instance: composition-da-0d9fdb5a39ccb7b71c8ef7225226fb5e
InstanceOf: CompositionUvEpi
Title: "Composition for emselex Package Leaflet"
Description:  "Composition for emselex Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mp0d9fdb5a39ccb7b71c8ef7225226fb5e)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - emselex"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #da
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Oversigt over indlægssedlen 
1. Virkning og anvendelse 
2. Det skal du vide, før du begynder at tage Emselex 
3. Sådan skal du tage Emselex 
4. Bivirkninger 
5. Opbevaring 
6. Pakningsstørrelser og yderligere oplysninger  </p>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What emselex is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What emselex is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Hvordan virker Emselex 
Emselex nedsætter aktiviteten af en overaktiv blære. Dette gør, at du kan vente længere, før du 
behøver at gå på toilettet, og det øger den urinmængde, som din blære kan holde på. </p>
<p>Hvad bruges Emselex til 
Emselex hører til gruppen af stoffer som virker afslappende på blæremusklen. Det anvendes til voksne 
til behandling af tilstande med symptomer på overaktiv blære - såsom pludselig trang til hurtigt at 
skulle på toilettet, behov for hyppige toiletbesøg og/eller ikke at nå på toilettet i tide og derfor bliver 
våd (urgeinkontinens). </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take emselex"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take emselex"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Tag ikke Emselex: </p>
<ul>
<li>
<p>hvis du er allergisk over for aliskiren eller et af de øvrige indholdsstoffer i Emselex (angivet i 
punkt 6). </p>
</li>
<li>
<p>hvis du har besvær med at tømme blæren (urinretension). </p>
</li>
<li>
<p>hvis du har svært ved at tømme mavesækken for indhold (ventrikelretention). </p>
</li>
<li>
<p>hvis du har højt tryk i øjet og ikke bliver behandlet for dette (snævervinklet glaukom). </p>
</li>
<li>
<p>hvis du har myastenia gravis (en sygdom, som markerer sig ved usædvanlig træthed og svaghed 
i bestemte muskler). </p>
</li>
<li>
<p>hvis du har svær tyktarmsbetændelse (colitis ulcerosa) eller toksisk megacolon (akut udvidelse 
af tyktarmen pga. komplikationer med infektion eller betændelse). </p>
</li>
<li>
<p>hvis du har alvorlige leverproblemer. </p>
</li>
<li>
<p>hvis du tager medicin der kraftigt nedsætter aktiviteten af nogle leverenzymer, såsom 
ciclosporin (medicin, der bruges i forbindelse med transplantation for at forhindre 
organafstødning eller til andre sygdomme fx reumatoid arthritis eller atopisk dermatitis), 
verapamil (medicin, der bruges til at sænke blodtrykket, til at korrigere hjerterytmen eller til at 
behandle angina pectoris), medicin mod svampeinfektioner (fx. ketoconazol og itraconazol) og 
visse antivirale lægemidler (fx ritonavir), - se afsnittet "Brug af anden medicin sammen med 
Emselex". </p>
</li>
</ul>
<p>Advarsler og forsigtighedsregler 
Kontakt lægen, før du tager Emselex </p>
<ul>
<li>
<p>hvis du har autonom neuropati (skade på nerverne, der kommunikerer mellem hjernen og indre 
organer, muskler, hud og blodårer for at regulere livsvigtige funktioner, inkl. hjerterytmen, 
blodtrykket og tarmfunktionen) - din læge vil have fortalt dig det, hvis du lider af dette. </p>
</li>
<li>
<p>hvis du har en tilstand, hvor et eller flere organer i maven har bevæget sig op i brystet gennem 
et åbning i mellemgulvet, der fører til halsbrand og hyppig bøvsning. </p>
</li>
<li>
<p>hvis du har besvær med at komme af med urinen og en svag urinstråle. </p>
</li>
<li>
<p>hvis du lider af svær forstoppelse (2 eller færre gange afføring om ugen). </p>
</li>
<li>
<p>hvis du har fordøjelsesproblemer. </p>
</li>
<li>
<p>hvis du har en obstruktiv mave-tarmlidelse (enhver tilstopning af passagen i mave-tarm-
kanalen, såsom forsnævring af pylorus, den nederste del af maven) - din læge vil have fortalt 
dig, hvis du lider af dette. </p>
</li>
<li>
<p>hvis du tager medicin, der kan forårsage eller forværre betændelse i spiserøret såsom orale 
bisfosfonater (en klasse af lægemidler, der forebygger tab af knoglemasse og bruges til 
behandling af knogleskørhed). </p>
</li>
<li>
<p>hvis du er i behandling for højt tryk i øjet (snævervinklet glaukom). </p>
</li>
<li>
<p>hvis du har en leversygdom. </p>
</li>
<li>
<p>hvis du har en urinvejsinfektion eller andre nyreproblemer. </p>
</li>
<li>
<p>hvis du har en overaktiv muskel, der kontrollerer tømningen af blæren, hvilket kan forårsage 
utilsigtet urinafgang (en tilstand kaldet detrusor overaktivitet) - din læge vil have fortalt dig, 
hvis du lider af dette. </p>
</li>
<li>
<p>hvis du har en hjertesygdom. 
Kontakt lægen, inden du begynder at tage Emselex, hvis nogen af ovenstående tilstande gælder for 
dig. </p>
</li>
</ul>
<p>Hvis du oplever hævelse af ansigt, læber, tunge og/eller svælg (tegn på angioødem) under behandling 
med Emselex, skal du straks kontakte lægen og stoppe med at tage Emselex. </p>
<p>Børn og unge 
Emselex frarådes til brug hos børn og unge (&lt;18 år). </p>
<p>Brug af anden medicin sammen med Emselex 
Fortæl det altid til lægen eller apotekspersonalet, hvis du bruger anden medicin eller har brugt det for 
nylig. Dette gælder også medicin, som ikke er købt på recept. Dette er specielt vigtigt, hvis du tager et 
af følgende lægemidler, da din læge muligvis skal justere din Emselexdosis og/eller det andet 
lægemiddel: </p>
<ul>
<li>
<p>visse antibiotika (fx erythromycin, clarithromycin, telithromycin og rifampicin), </p>
</li>
<li>
<p>medicin mod svampeinfektion (fx ketoconazol og itraconazol - se afsnittet "Tag ikke Emselex", 
fluconazole, terbinafin), </p>
</li>
<li>
<p>medicin som bruges til at undertrykke immunsystemet, for eksempel efter organtransplantation 
(fx ciclosporin - se afsnittet “Tag ikke Emselex"), </p>
</li>
<li>
<p>antivirale lægemidler (fx ritonavir - se afsnittet “Tag ikke Emselex"), </p>
</li>
<li>
<p>antipsykotisk medicin (fx thioridazin), </p>
</li>
<li>
<p>bestemte typer af medicin mod depression (fx imipramin og paroxetin), </p>
</li>
<li>
<p>visse krampestillende midler (carbamacepin, barbiturater), </p>
</li>
<li>
<p>visse typer af medicin som bruges til behandling af problemer med hjertet (fx verapamil - se 
afsnittet “Tag ikke Emselex", flecainid, digoxin og quinidin), </p>
</li>
<li>
<p>visse typer af medicin som bruges til behandling af maveproblemer (fx cimetidin), </p>
</li>
<li>
<p>andre antimuskarine lægemidler (fx tolterodin, oxybutynin og flavoxat). 
Du skal også fortælle din læge, hvis du tager medicin, der indeholder perikon. </p>
</li>
</ul>
<p>Brug af Emselex sammen med mad og drikke 
Indtagelse af mad har ingen indflydelse på virkningen af Emselex. Grapefrugtjuice kan påvirke 
virkningen af Emselex. Fortæl lægen, hvis du tager grapefrugtjuice regelmæssigt. </p>
<p>Graviditet og amning 
Hvis du er gravid eller ammer, har mistanke om, at du er gravid, eller planlægger at blive gravid, skal 
du spørge Deres din læge til råds, før De du tager bruger dette lægemiddel. 
Emselex frarådes under graviditet. 
Brug af Emselex bør ske med forsigtighed under amning. </p>
<p>Trafik- og arbejdssikkerhed 
Emselex kan give bivirkninger såsom svimmelhed, sløret syn, søvnproblemer eller døsighed. Hvis du 
oplever nogen af disse bivirkninger, mens du tager Emselex, skal du kontakte din læge for råd om 
ændring af doseringen eller overvejelse af alternativ behandling. Du bør ikke køre bil eller betjene 
maskiner, hvis du oplever disse bivirkninger. Disse bivirkninger er for Emselex rapporteret til at være 
"ikke almindelige" (se pkt. 4). </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take emselex"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take emselex"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Tag altid Emselex nøjagtigt efter lægens anvisning. Er du i tvivl så spørg lægen eller på apoteket. Hvis 
du mener, at virkningerne af Emselex er for kraftige eller for svage, bør du tale med din læge eller 
apotek herom. </p>
<p>Hvor meget Emselex skal du tage 
Den anbefalede startdosis er 7,5 mg daglig. Dette gælder også for patienter over 65 år. Afhængigt af 
virkningen af Emselex kan din læge øge doseringen til 15 mg daglig efter 2 ugers behandling. </p>
<p>Denne dosering er egnet til patienter med milde leversygdomme eller patienter med nyrelidelser. </p>
<p>Tag Emselex-tabletter en gang daglig sammen med væske, og på omtrent samme tid hver dag. </p>
<p>Tabletterne kan tages med eller uden mad. Tabletterne skal synkes hele. Tabletterne må ikke tygges, 
deles eller knuses. </p>
<p>Hvis du har taget for meget Emselex 
Hvis du har taget flere tabletter end lægen har foreskrevet, eller hvis en anden ved et uheld indtager 
dine tabletter, skal du straks henvende dig til din læge eller på skadestuen for at få råd. Når du søger 
lægehjælp, skal du sikre dig, at du medbringer denne indlægsseddel og pakningen med de resterende 
tabletter for at vise dem til lægen. Folk, der har taget en overdosis, kan få tørhed i munden, 
forstoppelse, hovedpine, fordøjelsesproblemer og tørhed i næsen. Overdosis af Emselex kan give 
svære symptomer, der kræver akut behandling på sygehus. </p>
<p>Hvis du har glemt at tage Emselex 
Hvis du har glemt at tage Emselex til sædvanlig tid, skal du tage medicinen så snart, du husker det. Du 
må ikke tage en dobbeltdosis som erstatning for den glemte dosis. </p>
<p>Hvis du holder op med at tage Emselex 
Din læge vil fortælle dig hvor længe behandlingen med Emselex skal vare. Du må ikke stoppe 
behandlingen, selvom du ikke mærker nogen umiddelbar virkning. Din blære har brug for nogen tid til 
at tilpasse sig. Gennemfør behandlingsforløbet som din læge har foreskrevet. Hvis du ikke har mærket 
nogen effekt ved behandlingens afslutning, skal du tale med din læge om det. </p>
<p>Spørg lægen eller på apoteket hvis der er noget, du er i tvivl om. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Dette lægemiddel kan som alle andre lægemidler give bivirkninger, men ikke alle får bivirkninger. 
Bivirkninger forårsaget af Emselex er normalt milde og forbigående. </p>
<p>Nogle bivirkninger kan være alvorlige 
Ikke kendt (hyppigheden kan ikke vurderes ud fra tilgængelige data) 
Alvorlige allergiske reaktioner inklusiv hævelse, hovedsageligt i ansigtet og halsen (angioødem). </p>
<p>Andre bivirkninger 
Meget almindelige (forekomme hos mere end 1 ud af 10 patienter) 
Mundtørhed, forstoppelse. </p>
<p>Almindelige bivirkninger (forekommer hos op til 1 ud af 10 patienter) 
Hovedpine, mavesmerter, nedsat fordøjelse, utilpashed, tørre øjne, tørhed i næsen. </p>
<p>Ikke almindelige (forekommer hos op til 1 ud af 100 patienter) 
Træthed, utilsigtede skader, hævelse i ansigtet, forhøjet blodtryk, diarré, flatulens, sår i 
mundslimhinden, forhøjede levertal (dette viser unormal funktion af leveren), hævelser inklusive 
hævelse af hænder, ankler eller fødder, svimmelhed, søvnløshed, døsighed, unormal tankegang, 
løbende næse (rinitis), hoste, åndenød, tør hud, kløe, hududslæt, svedtendens, synsforstyrrelser 
inklusive sløret syn, smagsforstyrrelser, urinvejsforstyrrelser eller -infektion, impotens, udflåd og kløe 
i skeden, blæresmerter, besvær med at tømme blæren. </p>
<p>Ikke kendt (kan ikke vurderes ud fra tilgængelige data) 
Nedtrykthed/humørsvingninger, hallucinationer. </p>
<p>Indberetning af bivirkninger 
Hvis du oplever bivirkninger, bør du tale med din læge eller apotekspersonalet. Dette gælder også 
mulige bivirkninger, som ikke er medtaget i denne indlægsseddel. Du eller dine pårørende kan også 
indberette bivirkninger direkte til Lægemiddelstyrelsen via det nationale rapporteringssystem anført i 
Appendiks V. Ved at indrapportere bivirkninger kan du hjælpe med at fremskaffe mere information 
om sikkerheden af dette lægemiddel. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store emselex"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store emselex"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <ul>
<li>
<p>Opbevar lægemidlet utilgængeligt for børn. </p>
</li>
<li>
<p>Brug ikke lægemidlet efter den udløbsdato, der står på pakningen og blisterkortet. Udløbsdatoen 
er den sidste dag i den nævnte måned. </p>
</li>
<li>
<p>Opbevar blisterpakningen i den ydre karton for at beskytte mod lys. </p>
</li>
<li>
<p>Brug ikke lægemidlet, hvis du bemærker at pakningen er beskadiget eller viser tegn på at have 
været åbnet. </p>
</li>
<li>
<p>Spørg på apoteket, hvordan du skal bortskaffe medicinrester. Af hensyn til miljøet må du ikke 
smide medicinrester i afløbet, toilettet eller skraldespanden. </p>
</li>
</ul>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Emselex indeholder 
- Aktivt stof: darifenacin. Hver tablet indeholder 7,5 mg darifenacin (som hydrobromid). 
- Øvrige indholdsstoffer: vandfrit calciumhydrogenphosphat, hypromellose, magnesiumstearat, 
polyethylenglycol, titandioxid (E171) og talcum. </p>
<p>Udseende og pakningsstørrelser 
Emselex 7,5 mg depottabletter er runde, konvekse, hvide tabletter, som er præget med "DF" på den 
ene side og "7.5" på den anden. </p>
<p>Tabletterne er tilgængelige i blisterpakninger, som indeholder 7, 14, 28, 49, 56 eller 98 tabletter eller 
som multipakninger indeholdende 140 (10x14) tabletter. Ikke alle pakningsstørrelser er nødvendigvis 
markedsført. </p>
<p>Indehaver af markedsføringstilladelsen 
pharmaand GmbH 
Taborstrasse 1 
1020 Wien 
Østrig </p>
<p>Fremstiller 
DREHM Pharma GmbH 
Grünbergstrasse 15/3/3 
1120 Wien 
Østrig </p>
<p>Denne indlægsseddel blev senest ændret  </p>
<p>Andre informationskilder 
Du kan finde yderligere information om Emselex på Det Europæiske Lægemiddelagenturs 
hjemmeside http://www.ema.europa.eu 
Indlægsseddel: information til brugeren </p>
<p>Emselex 15 mg depottabletter 
Darifenacin </p>
<p>Læs denne indlægsseddel grundigt, inden du begynder at tage dette lægemiddel, da den 
indeholder vigtige oplysninger. 
- Gem indlægssedlen. Du kan få brug for at læse den igen. 
- Spørg lægen eller apotekspersonalet, hvis der er mere du vil vide. 
- Lægen har ordineret dette lægemiddel til dig personligt. Lad derfor være med at give medicinen 
til andre. Det kan være skadeligt for andre, selvom de har de samme symptomer, som du har. 
- Kontakt lægen eller apotekspersonalet, hvis du får bivirkninger, herunder bivirkninger, som 
ikke er nævnt i denne indlægsseddel. Se punkt 4. </p>         </div>"""      





                    
Instance: bundlepackageleaflet-en-0d9fdb5a39ccb7b71c8ef7225226fb5e
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for emselex Package Leaflet for language en"
Description: "ePI document Bundle for emselex Package Leaflet for language en"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #en

// Composition
* entry[0].fullUrl = "Composition/composition-en-0d9fdb5a39ccb7b71c8ef7225226fb5e"
* entry[0].resource = composition-en-0d9fdb5a39ccb7b71c8ef7225226fb5e

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mp0d9fdb5a39ccb7b71c8ef7225226fb5e"
* entry[=].resource = mp0d9fdb5a39ccb7b71c8ef7225226fb5e
                            
                    
Instance: bundlepackageleaflet-da-0d9fdb5a39ccb7b71c8ef7225226fb5e
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for emselex Package Leaflet for language da"
Description: "ePI document Bundle for emselex Package Leaflet for language da"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #da

// Composition
* entry[0].fullUrl = "Composition/composition-da-0d9fdb5a39ccb7b71c8ef7225226fb5e"
* entry[0].resource = composition-da-0d9fdb5a39ccb7b71c8ef7225226fb5e

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mp0d9fdb5a39ccb7b71c8ef7225226fb5e"
* entry[=].resource = mp0d9fdb5a39ccb7b71c8ef7225226fb5e
                            
                    



Instance: mp0d9fdb5a39ccb7b71c8ef7225226fb5e
InstanceOf: MedicinalProductDefinitionUvEpi
Title: "Medicinal Product Emselex 7.5 mg prolonged-release tablets"
Description: "Emselex 7.5 mg prolonged-release tablets"
Usage: #inline

 
* identifier[+].system = "http://ema.europa.eu/identifier"
* identifier[=].value = "EU/1/04/294/001-006"
* type = http://hl7.org/fhir/medicinal-product-type#MedicinalProduct "Medicinal Product"

* domain = http://hl7.org/fhir/medicinal-product-domain#Human "Human use"

* status = http://hl7.org/fhir/publication-status#active "active"



* legalStatusOfSupply = $spor-rms#100000072084 "Medicinal product subject to medical prescription"

* name
  * productName = "Emselex 7.5 mg prolonged-release tablets"
  * type = $spor-productNamePartType-cs#220000000001 "Full name" 
  
  * part[0]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000002 "Invented name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000003 "Scientific name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000004 "Strength part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000005 "Pharmaceutical dose form part"
  
  * usage
    * country = urn:iso:std:iso:3166#EU "EU"
    * jurisdiction = urn:iso:std:iso:3166#EU "EU"
    * language = urn:ietf:bcp:47#en  "en"



RuleSet: 0d9fdb5a39ccb7b71c8ef7225226fb5eListRuleset

* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* identifier[+].system = "http://spor.ema.europa.eu/v2/medicine-name"
* identifier[=].value = "emselex"

* status = #current
* mode = #working

* title = "List of all ePIs associated with emselex"

* subject = Reference(mp0d9fdb5a39ccb7b71c8ef7225226fb5e)
* subject.extension[0].url = "http://ema.europa.eu/fhir/extension/medicine-name"
* subject.extension[=].valueCoding = $100000000005#emselex "emselex"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/marketing-authorization-holder"
* subject.extension[=].valueCoding = $100000000005#mah-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/active-substance"
* subject.extension[=].valueCoding = $100000000005#acive-substance-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/domain"
* subject.extension[=].valueCoding = $100000000004#100000000012 "H"

* date = "2015-02-07T13:28:17Z"


* entry
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-en-0d9fdb5a39ccb7b71c8ef7225226fb5e) // emselex en
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "en"



* entry
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-da-0d9fdb5a39ccb7b71c8ef7225226fb5e) // emselex da
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "da"




Instance: List-0d9fdb5a39ccb7b71c8ef7225226fb5e
InstanceOf: List

* insert 0d9fdb5a39ccb7b71c8ef7225226fb5eListRuleset
    